PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Name | miRBASE accession |
---|---|
mmu-miR-9-5p
|
MIMAT0000142 |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_-_14109219 | 9.73 |
ENSMUST00000230397.2
ENSMUST00000231567.2 ENSMUST00000090287.5 |
Myh11
|
myosin, heavy polypeptide 11, smooth muscle |
chr7_+_18828519 | 6.68 |
ENSMUST00000049454.6
|
Six5
|
sine oculis-related homeobox 5 |
chr16_-_21982049 | 6.27 |
ENSMUST00000100052.11
|
Igf2bp2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr9_+_69360902 | 5.93 |
ENSMUST00000034756.15
ENSMUST00000123470.8 |
Anxa2
|
annexin A2 |
chrX_-_141749704 | 5.45 |
ENSMUST00000041317.3
|
Ammecr1
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
chr6_-_82751429 | 5.35 |
ENSMUST00000000642.11
|
Hk2
|
hexokinase 2 |
chr16_+_24212284 | 5.15 |
ENSMUST00000038053.14
|
Lpp
|
LIM domain containing preferred translocation partner in lipoma |
chr7_-_144292257 | 4.96 |
ENSMUST00000121758.8
|
Ano1
|
anoctamin 1, calcium activated chloride channel |
chr7_-_118091135 | 4.94 |
ENSMUST00000178344.3
|
Itpripl2
|
inositol 1,4,5-triphosphate receptor interacting protein-like 2 |
chr12_-_16850674 | 4.85 |
ENSMUST00000162112.8
|
Greb1
|
gene regulated by estrogen in breast cancer protein |
chr12_+_8821317 | 4.77 |
ENSMUST00000020911.14
|
Sdc1
|
syndecan 1 |
chr2_-_125348305 | 4.76 |
ENSMUST00000028633.13
|
Fbn1
|
fibrillin 1 |
chr13_-_47083194 | 4.43 |
ENSMUST00000056978.8
|
Kif13a
|
kinesin family member 13A |
chrX_-_7054952 | 4.43 |
ENSMUST00000004428.14
|
Clcn5
|
chloride channel, voltage-sensitive 5 |
chr1_-_74163575 | 4.41 |
ENSMUST00000169786.8
ENSMUST00000212888.2 ENSMUST00000191104.7 |
Tns1
|
tensin 1 |
chr5_+_137348638 | 4.41 |
ENSMUST00000166239.8
ENSMUST00000111054.2 |
Ephb4
|
Eph receptor B4 |
chr12_-_87435091 | 4.20 |
ENSMUST00000021424.5
|
Sptlc2
|
serine palmitoyltransferase, long chain base subunit 2 |
chr11_-_7163897 | 4.20 |
ENSMUST00000020702.11
ENSMUST00000135887.3 |
Igfbp3
|
insulin-like growth factor binding protein 3 |
chr3_+_109030419 | 4.16 |
ENSMUST00000029477.11
|
Slc25a24
|
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24 |
chr5_+_30745447 | 4.12 |
ENSMUST00000066295.5
|
Kcnk3
|
potassium channel, subfamily K, member 3 |
chr17_-_32074754 | 4.12 |
ENSMUST00000024839.6
|
Sik1
|
salt inducible kinase 1 |
chr11_+_75541324 | 4.10 |
ENSMUST00000102505.10
|
Myo1c
|
myosin IC |
chr11_-_65160767 | 4.09 |
ENSMUST00000102635.10
|
Myocd
|
myocardin |
chr2_-_119985078 | 4.08 |
ENSMUST00000028755.8
|
Ehd4
|
EH-domain containing 4 |
chr17_+_29020064 | 4.06 |
ENSMUST00000004985.11
|
Brpf3
|
bromodomain and PHD finger containing, 3 |
chr1_-_131025562 | 4.06 |
ENSMUST00000016672.11
|
Mapkapk2
|
MAP kinase-activated protein kinase 2 |
chr4_+_47208004 | 3.92 |
ENSMUST00000082303.13
ENSMUST00000102917.11 |
Col15a1
|
collagen, type XV, alpha 1 |
chr11_-_100288566 | 3.91 |
ENSMUST00000001592.15
ENSMUST00000107403.2 |
Jup
|
junction plakoglobin |
chr14_+_99536111 | 3.90 |
ENSMUST00000005279.8
|
Klf5
|
Kruppel-like factor 5 |
chr2_-_65955338 | 3.85 |
ENSMUST00000028378.4
|
Galnt3
|
polypeptide N-acetylgalactosaminyltransferase 3 |
chr8_+_11362805 | 3.84 |
ENSMUST00000033899.14
|
Col4a2
|
collagen, type IV, alpha 2 |
chr10_-_128361731 | 3.82 |
ENSMUST00000026427.8
|
Esyt1
|
extended synaptotagmin-like protein 1 |
chr13_-_111945499 | 3.77 |
ENSMUST00000109267.9
|
Map3k1
|
mitogen-activated protein kinase kinase kinase 1 |
chr3_+_60408600 | 3.72 |
ENSMUST00000099087.8
|
Mbnl1
|
muscleblind like splicing factor 1 |
chr3_-_89186940 | 3.72 |
ENSMUST00000118860.2
ENSMUST00000029566.9 |
Efna1
|
ephrin A1 |
chr3_-_101017594 | 3.63 |
ENSMUST00000102694.4
|
Ptgfrn
|
prostaglandin F2 receptor negative regulator |
chr4_-_59549314 | 3.61 |
ENSMUST00000148331.9
ENSMUST00000030076.12 |
Ptbp3
|
polypyrimidine tract binding protein 3 |
chr5_+_73071607 | 3.59 |
ENSMUST00000144843.8
|
Slain2
|
SLAIN motif family, member 2 |
chr13_+_31809774 | 3.54 |
ENSMUST00000042054.3
|
Foxf2
|
forkhead box F2 |
chr9_+_62765362 | 3.54 |
ENSMUST00000213643.2
ENSMUST00000034777.14 ENSMUST00000163820.3 ENSMUST00000215870.2 ENSMUST00000214633.2 ENSMUST00000215968.2 |
Calml4
|
calmodulin-like 4 |
chr3_-_129126362 | 3.53 |
ENSMUST00000029658.14
|
Enpep
|
glutamyl aminopeptidase |
chr6_-_37419030 | 3.50 |
ENSMUST00000041093.6
|
Creb3l2
|
cAMP responsive element binding protein 3-like 2 |
chr17_+_88748139 | 3.46 |
ENSMUST00000112238.9
ENSMUST00000155640.2 |
Foxn2
|
forkhead box N2 |
chr16_+_29884153 | 3.44 |
ENSMUST00000023171.8
|
Hes1
|
hes family bHLH transcription factor 1 |
chr8_+_106786190 | 3.44 |
ENSMUST00000109308.3
|
Nfatc3
|
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 |
chr16_+_37597235 | 3.42 |
ENSMUST00000114763.3
|
Fstl1
|
follistatin-like 1 |
chr10_-_117681864 | 3.41 |
ENSMUST00000064667.9
|
Rap1b
|
RAS related protein 1b |
chr6_-_131365380 | 3.35 |
ENSMUST00000032309.13
ENSMUST00000087865.4 |
Ybx3
|
Y box protein 3 |
chr8_-_116434517 | 3.34 |
ENSMUST00000109104.2
|
Maf
|
avian musculoaponeurotic fibrosarcoma oncogene homolog |
chr10_+_69048464 | 3.33 |
ENSMUST00000020101.12
|
Rhobtb1
|
Rho-related BTB domain containing 1 |
chr6_-_136638926 | 3.33 |
ENSMUST00000032336.7
|
Plbd1
|
phospholipase B domain containing 1 |
chr17_-_25179635 | 3.32 |
ENSMUST00000024981.9
|
Jpt2
|
Jupiter microtubule associated homolog 2 |
chr6_+_91661034 | 3.31 |
ENSMUST00000032185.9
|
Slc6a6
|
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
chr10_+_79690452 | 3.28 |
ENSMUST00000165704.8
|
Ptbp1
|
polypyrimidine tract binding protein 1 |
chr3_+_89325750 | 3.26 |
ENSMUST00000039110.12
ENSMUST00000125036.8 ENSMUST00000191485.7 ENSMUST00000154791.8 |
Shc1
|
src homology 2 domain-containing transforming protein C1 |
chr5_+_77413282 | 3.21 |
ENSMUST00000080359.12
|
Rest
|
RE1-silencing transcription factor |
chr4_+_137004793 | 3.17 |
ENSMUST00000045747.5
|
Wnt4
|
wingless-type MMTV integration site family, member 4 |
chr7_-_80052491 | 3.16 |
ENSMUST00000122232.8
|
Furin
|
furin (paired basic amino acid cleaving enzyme) |
chr4_-_125021610 | 3.14 |
ENSMUST00000036188.8
|
Zc3h12a
|
zinc finger CCCH type containing 12A |
chr16_-_45664664 | 3.14 |
ENSMUST00000036355.13
|
Phldb2
|
pleckstrin homology like domain, family B, member 2 |
chr9_-_85209162 | 3.12 |
ENSMUST00000034802.15
|
Tent5a
|
terminal nucleotidyltransferase 5A |
chr6_-_52222776 | 3.12 |
ENSMUST00000048026.10
|
Hoxa11
|
homeobox A11 |
chr11_-_101357046 | 3.09 |
ENSMUST00000040430.8
|
Vat1
|
vesicle amine transport 1 |
chr3_-_100396635 | 3.07 |
ENSMUST00000061455.9
|
Tent5c
|
terminal nucleotidyltransferase 5C |
chr8_+_27575611 | 3.07 |
ENSMUST00000178514.8
ENSMUST00000033876.14 |
Adgra2
|
adhesion G protein-coupled receptor A2 |
chr5_+_92957231 | 2.97 |
ENSMUST00000113054.9
|
Shroom3
|
shroom family member 3 |
chr2_-_93164812 | 2.96 |
ENSMUST00000111265.9
|
Tspan18
|
tetraspanin 18 |
chr17_+_87270504 | 2.96 |
ENSMUST00000024956.15
|
Rhoq
|
ras homolog family member Q |
chr10_-_70995485 | 2.92 |
ENSMUST00000014473.6
ENSMUST00000143791.8 |
Bicc1
|
BicC family RNA binding protein 1 |
chr3_-_131138541 | 2.89 |
ENSMUST00000090246.5
ENSMUST00000126569.2 |
Sgms2
|
sphingomyelin synthase 2 |
chr3_-_102111892 | 2.88 |
ENSMUST00000029453.13
|
Vangl1
|
VANGL planar cell polarity 1 |
chr15_+_7840327 | 2.84 |
ENSMUST00000022744.5
|
Gdnf
|
glial cell line derived neurotrophic factor |
chr3_+_106455114 | 2.83 |
ENSMUST00000067630.13
ENSMUST00000134396.8 ENSMUST00000121034.8 ENSMUST00000029507.13 ENSMUST00000144746.8 ENSMUST00000132923.8 ENSMUST00000151465.2 |
Dram2
|
DNA-damage regulated autophagy modulator 2 |
chr12_+_70872266 | 2.78 |
ENSMUST00000057859.9
|
Frmd6
|
FERM domain containing 6 |
chr13_+_56757389 | 2.76 |
ENSMUST00000045173.10
|
Tgfbi
|
transforming growth factor, beta induced |
chr4_-_136563154 | 2.76 |
ENSMUST00000105846.9
ENSMUST00000059287.14 ENSMUST00000105845.9 |
Ephb2
|
Eph receptor B2 |
chr2_-_60793536 | 2.73 |
ENSMUST00000028347.13
|
Rbms1
|
RNA binding motif, single stranded interacting protein 1 |
chr5_+_114912738 | 2.72 |
ENSMUST00000102578.11
|
Ankrd13a
|
ankyrin repeat domain 13a |
chr18_+_75953244 | 2.71 |
ENSMUST00000058997.15
|
Zbtb7c
|
zinc finger and BTB domain containing 7C |
chr6_-_92920466 | 2.69 |
ENSMUST00000113438.8
|
Adamts9
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 9 |
chr5_-_96309849 | 2.68 |
ENSMUST00000155901.8
|
Cnot6l
|
CCR4-NOT transcription complex, subunit 6-like |
chr3_-_53564759 | 2.67 |
ENSMUST00000091137.6
|
Frem2
|
Fras1 related extracellular matrix protein 2 |
chr14_-_101846459 | 2.66 |
ENSMUST00000161991.8
|
Tbc1d4
|
TBC1 domain family, member 4 |
chr18_+_61178211 | 2.59 |
ENSMUST00000025522.11
ENSMUST00000115274.2 |
Pdgfrb
|
platelet derived growth factor receptor, beta polypeptide |
chr3_+_89427458 | 2.58 |
ENSMUST00000000811.8
|
Kcnn3
|
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 |
chr14_+_65596070 | 2.55 |
ENSMUST00000066994.7
|
Zfp395
|
zinc finger protein 395 |
chr1_-_13660027 | 2.54 |
ENSMUST00000027068.11
|
Tram1
|
translocating chain-associating membrane protein 1 |
chr13_+_111822712 | 2.54 |
ENSMUST00000109272.9
|
Mier3
|
MIER family member 3 |
chr9_+_102594867 | 2.53 |
ENSMUST00000035121.14
|
Amotl2
|
angiomotin-like 2 |
chr1_-_134006847 | 2.53 |
ENSMUST00000020692.7
|
Btg2
|
BTG anti-proliferation factor 2 |
chr12_-_54250646 | 2.50 |
ENSMUST00000039516.4
|
Egln3
|
egl-9 family hypoxia-inducible factor 3 |
chr8_+_93687561 | 2.48 |
ENSMUST00000072939.8
|
Slc6a2
|
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
chr13_+_117356808 | 2.47 |
ENSMUST00000022242.9
|
Emb
|
embigin |
chr19_+_59249316 | 2.44 |
ENSMUST00000026084.5
|
Slc18a2
|
solute carrier family 18 (vesicular monoamine), member 2 |
chr12_+_111005768 | 2.44 |
ENSMUST00000084968.14
|
Rcor1
|
REST corepressor 1 |
chr10_-_44334711 | 2.43 |
ENSMUST00000039174.11
|
Prdm1
|
PR domain containing 1, with ZNF domain |
chr19_-_41252370 | 2.43 |
ENSMUST00000237871.2
ENSMUST00000025989.10 |
Tm9sf3
|
transmembrane 9 superfamily member 3 |
chr4_+_118384426 | 2.41 |
ENSMUST00000030261.6
|
2610528J11Rik
|
RIKEN cDNA 2610528J11 gene |
chr11_-_80670815 | 2.39 |
ENSMUST00000041065.14
ENSMUST00000070997.6 |
Myo1d
|
myosin ID |
chr18_+_35251912 | 2.37 |
ENSMUST00000042345.8
ENSMUST00000236037.2 |
Ctnna1
|
catenin (cadherin associated protein), alpha 1 |
chr14_-_54815000 | 2.36 |
ENSMUST00000054487.10
|
Ajuba
|
ajuba LIM protein |
chr7_+_141047298 | 2.35 |
ENSMUST00000106000.10
ENSMUST00000209892.2 ENSMUST00000177840.9 |
Cd151
|
CD151 antigen |
chr16_-_85698679 | 2.34 |
ENSMUST00000023611.7
|
Adamts5
|
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 5 (aggrecanase-2) |
chr4_+_62204678 | 2.33 |
ENSMUST00000084530.9
|
Slc31a2
|
solute carrier family 31, member 2 |
chrX_-_161671421 | 2.33 |
ENSMUST00000033723.4
|
Syap1
|
synapse associated protein 1 |
chr5_+_103902020 | 2.32 |
ENSMUST00000054979.10
|
Aff1
|
AF4/FMR2 family, member 1 |
chr14_+_70782788 | 2.32 |
ENSMUST00000047218.5
|
Reep4
|
receptor accessory protein 4 |
chr4_-_152080634 | 2.31 |
ENSMUST00000055688.10
|
Phf13
|
PHD finger protein 13 |
chr7_-_109464793 | 2.30 |
ENSMUST00000007423.12
ENSMUST00000106728.3 ENSMUST00000106729.8 |
Scube2
|
signal peptide, CUB domain, EGF-like 2 |
chr2_+_71617266 | 2.26 |
ENSMUST00000112101.8
ENSMUST00000028522.10 |
Itga6
|
integrin alpha 6 |
chr13_-_116446166 | 2.26 |
ENSMUST00000036060.13
|
Isl1
|
ISL1 transcription factor, LIM/homeodomain |
chr15_-_77726333 | 2.26 |
ENSMUST00000016771.13
|
Myh9
|
myosin, heavy polypeptide 9, non-muscle |
chr3_-_27764571 | 2.25 |
ENSMUST00000046157.10
|
Fndc3b
|
fibronectin type III domain containing 3B |
chr12_+_116244792 | 2.24 |
ENSMUST00000100986.4
ENSMUST00000220816.2 |
Esyt2
|
extended synaptotagmin-like protein 2 |
chr17_-_74601769 | 2.23 |
ENSMUST00000078459.8
ENSMUST00000232989.2 |
Memo1
|
mediator of cell motility 1 |
chr2_+_118756973 | 2.23 |
ENSMUST00000099546.6
ENSMUST00000110837.2 |
Chst14
|
carbohydrate sulfotransferase 14 |
chr17_-_48235560 | 2.22 |
ENSMUST00000113265.8
|
Foxp4
|
forkhead box P4 |
chr12_-_102844537 | 2.21 |
ENSMUST00000045652.8
ENSMUST00000223554.2 |
Btbd7
|
BTB (POZ) domain containing 7 |
chr17_-_14914484 | 2.20 |
ENSMUST00000170872.3
|
Thbs2
|
thrombospondin 2 |
chr18_+_14916295 | 2.19 |
ENSMUST00000234789.2
ENSMUST00000169862.2 |
Taf4b
|
TATA-box binding protein associated factor 4b |
chr6_+_70933434 | 2.19 |
ENSMUST00000163089.2
ENSMUST00000069634.6 |
Foxi3
|
forkhead box I3 |
chr11_-_78056347 | 2.17 |
ENSMUST00000017530.4
|
Traf4
|
TNF receptor associated factor 4 |
chr12_-_54703281 | 2.17 |
ENSMUST00000056228.8
|
Sptssa
|
serine palmitoyltransferase, small subunit A |
chr1_-_119349969 | 2.16 |
ENSMUST00000038765.6
|
Inhbb
|
inhibin beta-B |
chr14_+_59862751 | 2.16 |
ENSMUST00000053949.7
|
Shisa2
|
shisa family member 2 |
chr10_-_40018243 | 2.16 |
ENSMUST00000092566.8
ENSMUST00000213488.2 |
Slc16a10
|
solute carrier family 16 (monocarboxylic acid transporters), member 10 |
chr12_+_69418886 | 2.15 |
ENSMUST00000050063.9
|
Arf6
|
ADP-ribosylation factor 6 |
chrX_+_98179725 | 2.15 |
ENSMUST00000052839.7
|
Efnb1
|
ephrin B1 |
chr3_-_87081939 | 2.13 |
ENSMUST00000159976.8
ENSMUST00000107618.9 |
Kirrel
|
kirre like nephrin family adhesion molecule 1 |
chr1_-_69724939 | 2.13 |
ENSMUST00000027146.9
|
Ikzf2
|
IKAROS family zinc finger 2 |
chr4_+_97665843 | 2.12 |
ENSMUST00000075448.13
ENSMUST00000092532.13 |
Nfia
|
nuclear factor I/A |
chr13_+_14129054 | 2.12 |
ENSMUST00000099747.5
|
B3galnt2
|
UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 2 |
chr6_-_39183712 | 2.11 |
ENSMUST00000002305.9
|
Kdm7a
|
lysine (K)-specific demethylase 7A |
chr7_-_110462446 | 2.11 |
ENSMUST00000033050.5
|
Lyve1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chrX_-_166165743 | 2.10 |
ENSMUST00000026839.5
|
Prps2
|
phosphoribosyl pyrophosphate synthetase 2 |
chr14_+_20979466 | 2.10 |
ENSMUST00000022369.9
|
Vcl
|
vinculin |
chr14_-_47426863 | 2.10 |
ENSMUST00000089959.7
|
Gch1
|
GTP cyclohydrolase 1 |
chr11_+_32297803 | 2.10 |
ENSMUST00000038753.6
ENSMUST00000239041.2 |
Sh3pxd2b
|
SH3 and PX domains 2B |
chr4_-_151142351 | 2.08 |
ENSMUST00000030797.4
|
Vamp3
|
vesicle-associated membrane protein 3 |
chr4_+_123798625 | 2.08 |
ENSMUST00000030400.14
|
Mycbp
|
MYC binding protein |
chrX_+_138511360 | 2.08 |
ENSMUST00000113026.2
|
Rnf128
|
ring finger protein 128 |
chr5_-_114518566 | 2.08 |
ENSMUST00000102581.11
|
Kctd10
|
potassium channel tetramerisation domain containing 10 |
chr5_+_146168020 | 2.07 |
ENSMUST00000161181.8
ENSMUST00000161652.8 ENSMUST00000031640.15 ENSMUST00000159467.2 |
Cdk8
|
cyclin-dependent kinase 8 |
chr10_-_120312374 | 2.07 |
ENSMUST00000072777.14
ENSMUST00000159699.2 |
Hmga2
|
high mobility group AT-hook 2 |
chr15_+_10177709 | 2.06 |
ENSMUST00000124470.8
|
Prlr
|
prolactin receptor |
chr18_+_64473091 | 2.06 |
ENSMUST00000175965.10
|
Onecut2
|
one cut domain, family member 2 |
chr16_+_42727926 | 2.05 |
ENSMUST00000151244.8
ENSMUST00000114694.9 |
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr11_+_95010935 | 2.05 |
ENSMUST00000092768.7
|
Dlx3
|
distal-less homeobox 3 |
chr9_-_116004265 | 2.04 |
ENSMUST00000061101.12
|
Tgfbr2
|
transforming growth factor, beta receptor II |
chr9_-_115139489 | 2.03 |
ENSMUST00000035010.10
|
Stt3b
|
STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae) |
chr4_-_84593512 | 2.02 |
ENSMUST00000176612.8
|
Bnc2
|
basonuclin 2 |
chr7_+_86895851 | 2.02 |
ENSMUST00000032781.14
|
Nox4
|
NADPH oxidase 4 |
chr1_-_136888118 | 2.01 |
ENSMUST00000192357.6
ENSMUST00000027649.14 |
Nr5a2
|
nuclear receptor subfamily 5, group A, member 2 |
chr4_-_133480922 | 2.01 |
ENSMUST00000145664.9
ENSMUST00000105897.10 |
Arid1a
|
AT rich interactive domain 1A (SWI-like) |
chr3_+_63203516 | 2.01 |
ENSMUST00000029400.7
|
Mme
|
membrane metallo endopeptidase |
chr2_-_34803988 | 2.01 |
ENSMUST00000028232.7
ENSMUST00000202907.2 |
Phf19
|
PHD finger protein 19 |
chr9_+_30941924 | 2.01 |
ENSMUST00000216649.2
ENSMUST00000115222.10 |
Zbtb44
|
zinc finger and BTB domain containing 44 |
chr9_-_32452885 | 2.01 |
ENSMUST00000016231.14
|
Fli1
|
Friend leukemia integration 1 |
chr3_+_97920819 | 2.00 |
ENSMUST00000079812.8
|
Notch2
|
notch 2 |
chr11_+_44508137 | 2.00 |
ENSMUST00000109268.2
ENSMUST00000101326.10 ENSMUST00000081265.12 |
Ebf1
|
early B cell factor 1 |
chr13_-_104057016 | 2.00 |
ENSMUST00000022222.12
|
Erbin
|
Erbb2 interacting protein |
chr13_-_38712387 | 1.99 |
ENSMUST00000035988.16
|
Txndc5
|
thioredoxin domain containing 5 |
chr6_-_100264439 | 1.99 |
ENSMUST00000101118.4
|
Rybp
|
RING1 and YY1 binding protein |
chr2_+_3714492 | 1.99 |
ENSMUST00000027965.11
|
Fam107b
|
family with sequence similarity 107, member B |
chr7_-_34089109 | 1.98 |
ENSMUST00000085585.12
|
Lsm14a
|
LSM14A mRNA processing body assembly factor |
chr9_-_8004586 | 1.98 |
ENSMUST00000086580.12
ENSMUST00000065353.13 |
Yap1
|
yes-associated protein 1 |
chr8_+_96078886 | 1.98 |
ENSMUST00000034243.7
|
Mmp15
|
matrix metallopeptidase 15 |
chr11_-_47270201 | 1.98 |
ENSMUST00000077221.6
|
Sgcd
|
sarcoglycan, delta (dystrophin-associated glycoprotein) |
chr1_-_190915441 | 1.98 |
ENSMUST00000027941.14
|
Atf3
|
activating transcription factor 3 |
chr13_-_89890609 | 1.97 |
ENSMUST00000109546.9
|
Vcan
|
versican |
chr15_-_100952206 | 1.97 |
ENSMUST00000178140.2
|
Fignl2
|
fidgetin-like 2 |
chr9_-_96993169 | 1.96 |
ENSMUST00000085206.11
|
Slc25a36
|
solute carrier family 25, member 36 |
chr4_+_148025316 | 1.95 |
ENSMUST00000103232.2
|
2510039O18Rik
|
RIKEN cDNA 2510039O18 gene |
chr2_-_73360069 | 1.95 |
ENSMUST00000094681.11
|
Wipf1
|
WAS/WASL interacting protein family, member 1 |
chr7_-_26928029 | 1.95 |
ENSMUST00000003850.8
|
Itpkc
|
inositol 1,4,5-trisphosphate 3-kinase C |
chr7_+_88079465 | 1.93 |
ENSMUST00000107256.4
|
Rab38
|
RAB38, member RAS oncogene family |
chr3_-_69767208 | 1.93 |
ENSMUST00000171529.4
ENSMUST00000051239.13 |
Sptssb
|
serine palmitoyltransferase, small subunit B |
chr6_+_14901343 | 1.93 |
ENSMUST00000115477.8
|
Foxp2
|
forkhead box P2 |
chr11_+_60822859 | 1.92 |
ENSMUST00000019076.10
|
Map2k3
|
mitogen-activated protein kinase kinase 3 |
chr10_-_62067026 | 1.91 |
ENSMUST00000047883.11
|
Tspan15
|
tetraspanin 15 |
chr11_+_68858942 | 1.90 |
ENSMUST00000102606.10
ENSMUST00000018884.6 |
Slc25a35
|
solute carrier family 25, member 35 |
chr9_+_109704609 | 1.90 |
ENSMUST00000094324.8
|
Cdc25a
|
cell division cycle 25A |
chr9_+_121946321 | 1.89 |
ENSMUST00000119215.9
ENSMUST00000146832.8 ENSMUST00000118886.9 ENSMUST00000120173.9 ENSMUST00000139181.2 |
Snrk
|
SNF related kinase |
chr2_-_126718129 | 1.89 |
ENSMUST00000103224.10
|
Trpm7
|
transient receptor potential cation channel, subfamily M, member 7 |
chr4_+_63133639 | 1.89 |
ENSMUST00000036300.13
|
Col27a1
|
collagen, type XXVII, alpha 1 |
chr9_-_119151428 | 1.88 |
ENSMUST00000040853.11
|
Oxsr1
|
oxidative-stress responsive 1 |
chr17_-_66258110 | 1.88 |
ENSMUST00000233580.2
ENSMUST00000024906.6 |
Twsg1
|
twisted gastrulation BMP signaling modulator 1 |
chr12_+_105651643 | 1.88 |
ENSMUST00000051934.7
|
Gskip
|
GSK3B interacting protein |
chr18_-_73836810 | 1.87 |
ENSMUST00000025393.14
|
Smad4
|
SMAD family member 4 |
chr1_-_165830160 | 1.87 |
ENSMUST00000111429.11
ENSMUST00000176800.2 ENSMUST00000177358.8 |
Pou2f1
|
POU domain, class 2, transcription factor 1 |
chr7_+_65759198 | 1.86 |
ENSMUST00000036372.8
|
Chsy1
|
chondroitin sulfate synthase 1 |
chr15_-_35155896 | 1.85 |
ENSMUST00000067033.8
ENSMUST00000018476.14 |
Stk3
|
serine/threonine kinase 3 |
chr8_-_84059048 | 1.84 |
ENSMUST00000177594.8
ENSMUST00000053902.4 |
Elmod2
|
ELMO/CED-12 domain containing 2 |
chr17_+_56610321 | 1.84 |
ENSMUST00000001258.15
|
Uhrf1
|
ubiquitin-like, containing PHD and RING finger domains, 1 |
chr3_+_52175757 | 1.83 |
ENSMUST00000053764.7
|
Foxo1
|
forkhead box O1 |
chr3_-_117662575 | 1.82 |
ENSMUST00000029639.12
|
Snx7
|
sorting nexin 7 |
chr1_-_128520002 | 1.82 |
ENSMUST00000052172.7
ENSMUST00000142893.2 |
Cxcr4
|
chemokine (C-X-C motif) receptor 4 |
chr11_+_53991750 | 1.82 |
ENSMUST00000093107.12
ENSMUST00000019050.12 ENSMUST00000174616.8 ENSMUST00000129499.8 ENSMUST00000126840.8 |
P4ha2
|
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase), alpha II polypeptide |
chr6_-_5496261 | 1.81 |
ENSMUST00000203347.3
ENSMUST00000019721.7 |
Pdk4
|
pyruvate dehydrogenase kinase, isoenzyme 4 |
chr4_-_134495234 | 1.81 |
ENSMUST00000037828.8
|
Ldlrap1
|
low density lipoprotein receptor adaptor protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:0048627 | myoblast development(GO:0048627) |
1.5 | 9.1 | GO:0032804 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
1.4 | 4.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
1.4 | 4.1 | GO:2000722 | regulation of phenotypic switching(GO:1900239) negative regulation of vascular associated smooth muscle cell migration(GO:1904753) regulation of cardiac vascular smooth muscle cell differentiation(GO:2000722) positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
1.3 | 4.0 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.3 | 3.8 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
1.2 | 4.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
1.1 | 3.4 | GO:2000978 | trochlear nerve development(GO:0021558) auditory receptor cell fate determination(GO:0042668) negative regulation of forebrain neuron differentiation(GO:2000978) |
1.1 | 3.3 | GO:0015734 | beta-alanine transport(GO:0001762) taurine transport(GO:0015734) |
1.1 | 5.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
1.1 | 3.2 | GO:2000019 | positive regulation of dermatome development(GO:0061184) renal vesicle induction(GO:0072034) negative regulation of male gonad development(GO:2000019) |
1.0 | 4.2 | GO:2000843 | testosterone secretion(GO:0035936) negative regulation of steroid hormone secretion(GO:2000832) regulation of testosterone secretion(GO:2000843) |
1.0 | 4.0 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
1.0 | 2.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
1.0 | 11.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.9 | 2.8 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.8 | 3.4 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.8 | 2.4 | GO:0033082 | regulation of extrathymic T cell differentiation(GO:0033082) |
0.8 | 3.9 | GO:0002159 | desmosome assembly(GO:0002159) |
0.8 | 5.3 | GO:1903849 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.8 | 3.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.8 | 2.3 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) peripheral nervous system neuron axonogenesis(GO:0048936) |
0.7 | 1.5 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.7 | 3.7 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.7 | 1.5 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.7 | 4.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 2.8 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.7 | 2.0 | GO:0002514 | B cell tolerance induction(GO:0002514) regulation of tolerance induction to self antigen(GO:0002649) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.7 | 2.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.6 | 3.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.6 | 1.9 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.6 | 3.7 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) notochord formation(GO:0014028) |
0.6 | 3.1 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.6 | 0.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 4.2 | GO:0015867 | ATP transport(GO:0015867) |
0.6 | 1.8 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.6 | 4.7 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.6 | 2.3 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.6 | 2.8 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.5 | 3.3 | GO:1990839 | response to endothelin(GO:1990839) |
0.5 | 2.1 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.5 | 2.1 | GO:0014916 | regulation of lung blood pressure(GO:0014916) |
0.5 | 4.1 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.5 | 4.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 2.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.5 | 1.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.5 | 4.1 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 3.5 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.5 | 2.0 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.5 | 4.3 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.5 | 1.9 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.5 | 1.8 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.5 | 1.8 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.5 | 5.0 | GO:0015705 | iodide transport(GO:0015705) |
0.4 | 3.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.4 | 6.7 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.4 | 1.7 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.4 | 1.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.4 | 1.6 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.4 | 2.8 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 2.4 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.4 | 1.6 | GO:0033380 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
0.4 | 2.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.4 | 1.5 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.4 | 1.5 | GO:0001579 | medium-chain fatty acid transport(GO:0001579) |
0.4 | 3.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.4 | 4.1 | GO:0044351 | macropinocytosis(GO:0044351) |
0.4 | 1.8 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.4 | 1.1 | GO:0048822 | enucleate erythrocyte development(GO:0048822) |
0.4 | 1.1 | GO:0071335 | hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) |
0.4 | 0.7 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.4 | 5.8 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
0.4 | 1.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.4 | 1.8 | GO:0036343 | psychomotor behavior(GO:0036343) |
0.3 | 2.4 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.3 | 3.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.3 | 1.7 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 2.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 1.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.3 | 2.0 | GO:0070433 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.3 | 1.3 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 1.6 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 1.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.3 | 1.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.3 | 1.9 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.3 | 1.5 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.3 | 3.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 3.3 | GO:1901249 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
0.3 | 2.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 2.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 1.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.3 | 1.7 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.3 | 2.3 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
0.3 | 2.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.3 | 4.5 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.3 | 1.1 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.3 | 1.9 | GO:0090383 | platelet dense granule organization(GO:0060155) phagosome acidification(GO:0090383) melanosome assembly(GO:1903232) |
0.3 | 1.3 | GO:0010157 | response to chlorate(GO:0010157) |
0.3 | 1.9 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 2.9 | GO:1902913 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.3 | 0.5 | GO:0060769 | positive regulation of epithelial cell proliferation involved in prostate gland development(GO:0060769) |
0.3 | 1.8 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.2 | 3.0 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 2.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.5 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.2 | 0.7 | GO:2001200 | positive regulation of dendritic cell differentiation(GO:2001200) |
0.2 | 1.7 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 2.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 2.3 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 3.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 4.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 3.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 1.1 | GO:1905171 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
0.2 | 2.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.2 | 0.9 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.2 | 0.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.2 | 2.7 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.2 | 0.8 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
0.2 | 2.5 | GO:0035879 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 2.3 | GO:0035878 | nail development(GO:0035878) |
0.2 | 2.4 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.2 | 2.8 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.8 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.2 | 1.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.2 | 1.5 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.2 | 1.0 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 1.5 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 1.1 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.2 | 1.7 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.2 | 0.6 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.2 | 1.7 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
0.2 | 2.2 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 0.7 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.2 | 3.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 1.1 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 1.6 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.2 | 2.3 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.2 | 2.7 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.2 | 2.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 3.8 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.5 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.2 | 2.1 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 3.7 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.2 | 3.2 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.2 | 0.6 | GO:0035521 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.2 | 3.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.4 | GO:0035037 | sperm entry(GO:0035037) |
0.1 | 1.0 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 3.3 | GO:0051923 | sulfation(GO:0051923) |
0.1 | 0.9 | GO:0097466 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 4.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 2.2 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.1 | 6.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.5 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 2.1 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.1 | 2.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 1.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.1 | 0.6 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 1.6 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
0.1 | 2.1 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 1.0 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 5.3 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.1 | 2.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 2.0 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 1.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 1.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.5 | GO:0009305 | protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 2.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 2.2 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 1.3 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.8 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 0.6 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 2.7 | GO:0043486 | histone exchange(GO:0043486) |
0.1 | 0.5 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.1 | 2.0 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 2.0 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 2.2 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 1.8 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.1 | 0.4 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 2.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.9 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 1.9 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.6 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.1 | 0.3 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.1 | 0.9 | GO:0060283 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.1 | 1.3 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.1 | 2.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 1.3 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 3.3 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.1 | 0.9 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.1 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.1 | 0.3 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.1 | 0.8 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.1 | 0.9 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 2.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.4 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.1 | 0.5 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.5 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.1 | 1.7 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 2.1 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.1 | 0.2 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
0.1 | 0.9 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.1 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.1 | 0.5 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 2.0 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 1.1 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) |
0.1 | 1.9 | GO:1902751 | positive regulation of cell cycle G2/M phase transition(GO:1902751) |
0.1 | 0.2 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.1 | 3.5 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 4.4 | GO:0010761 | fibroblast migration(GO:0010761) |
0.1 | 2.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.1 | 1.3 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 1.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 2.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 0.2 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.1 | 3.3 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.1 | 1.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 2.2 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.1 | 0.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 4.0 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.5 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 2.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 1.0 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.7 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 1.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.0 | 0.7 | GO:1901673 | regulation of mitotic spindle assembly(GO:1901673) |
0.0 | 0.4 | GO:0001842 | neural fold formation(GO:0001842) |
0.0 | 3.0 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 3.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 1.4 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
0.0 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.0 | 0.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 1.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.0 | 1.9 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
0.0 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.0 | 0.6 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.0 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 1.0 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.0 | 0.6 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.0 | 0.3 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 1.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 1.1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.0 | 3.0 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.6 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:1903281 | positive regulation of calcium:sodium antiporter activity(GO:1903281) |
0.0 | 0.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.5 | GO:0060351 | cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
0.0 | 0.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.5 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 2.2 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.8 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 0.1 | GO:1900736 | negative regulation of phospholipase C activity(GO:1900275) regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
0.0 | 0.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.0 | 1.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.7 | GO:0030901 | midbrain development(GO:0030901) |
0.0 | 1.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 1.1 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 2.4 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 2.2 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.0 | 1.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.0 | GO:1904908 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.0 | 2.1 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.0 | 1.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 2.0 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 1.1 | GO:0035904 | aorta development(GO:0035904) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.9 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.0 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.0 | 1.4 | GO:0048477 | oogenesis(GO:0048477) |
0.0 | 0.9 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.0 | 0.7 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.3 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.0 | 0.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 2.2 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.3 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.2 | GO:0003170 | heart valve development(GO:0003170) |
0.0 | 0.5 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.7 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.1 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.0 | 1.2 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.2 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.9 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.0 | 1.1 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.4 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 2.0 | GO:0055001 | muscle cell development(GO:0055001) |
0.0 | 0.9 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.5 | GO:0048265 | response to pain(GO:0048265) |
0.0 | 0.5 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 5.9 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
1.1 | 3.3 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
1.1 | 9.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 8.3 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.8 | 4.1 | GO:0045160 | myosin I complex(GO:0045160) |
0.7 | 2.0 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.5 | 3.8 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.5 | 2.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 2.0 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
0.5 | 4.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.4 | 3.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.4 | 4.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 3.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.4 | 1.6 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.4 | 0.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.4 | 1.9 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 1.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 1.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 3.9 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.3 | 7.3 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.3 | 3.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.3 | 5.4 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.3 | 3.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.8 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
0.3 | 1.1 | GO:0043511 | inhibin complex(GO:0043511) |
0.3 | 3.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 1.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 3.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.2 | 1.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.4 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 1.6 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 2.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 3.6 | GO:0090543 | Flemming body(GO:0090543) |
0.2 | 1.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 0.6 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.2 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 3.1 | GO:0045180 | basal cortex(GO:0045180) |
0.2 | 4.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 2.4 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 2.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 1.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 4.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 1.6 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 16.5 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 2.1 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.4 | GO:0090537 | CERF complex(GO:0090537) |
0.1 | 0.9 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 1.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.1 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 0.7 | GO:0042585 | germinal vesicle(GO:0042585) |
0.1 | 4.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 3.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 1.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 1.4 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.5 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 4.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 3.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 0.9 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 14.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 0.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.5 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 3.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.9 | GO:0042555 | MCM complex(GO:0042555) |
0.1 | 1.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.4 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 5.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 3.4 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 1.4 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.2 | GO:0061474 | phagolysosome membrane(GO:0061474) |
0.1 | 2.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 2.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 2.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 0.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.7 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 2.4 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 1.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 8.6 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 2.8 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 2.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.1 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.0 | 4.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 4.5 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.6 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.0 | 1.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 13.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 7.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 3.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.5 | GO:0090544 | BAF-type complex(GO:0090544) |
0.0 | 1.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 16.1 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.1 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.0 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.8 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.0 | 1.2 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 1.8 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 1.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 2.6 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 13.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.0 | 0.3 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.6 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 11.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 1.9 | GO:0016605 | PML body(GO:0016605) |
0.0 | 4.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.5 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 6.0 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 37.8 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 1.6 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.4 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.2 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 0.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 1.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) cation-transporting ATPase complex(GO:0090533) |
0.0 | 24.8 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 3.8 | GO:0031012 | extracellular matrix(GO:0031012) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 8.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
1.1 | 3.4 | GO:0071820 | N-box binding(GO:0071820) |
1.1 | 3.3 | GO:0005368 | beta-alanine transmembrane transporter activity(GO:0001761) taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
1.0 | 4.2 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.9 | 2.8 | GO:0030116 | glial cell-derived neurotrophic factor receptor binding(GO:0030116) |
0.9 | 2.6 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.8 | 2.5 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.8 | 5.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.7 | 3.4 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.7 | 4.1 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.7 | 2.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.7 | 5.3 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.7 | 5.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 1.9 | GO:0036461 | BLOC-2 complex binding(GO:0036461) |
0.6 | 3.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.6 | 1.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.5 | 3.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.5 | 7.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.5 | 2.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.5 | 1.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 3.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 1.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 1.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.2 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.4 | 1.7 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.4 | 1.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.4 | 2.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.4 | 1.7 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.4 | 2.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.4 | 1.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.4 | 2.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 3.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.4 | 3.8 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 4.2 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.4 | 5.8 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 4.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.3 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.3 | 8.7 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 0.9 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.3 | 2.6 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.3 | 3.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.3 | 1.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.3 | 1.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 2.2 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.4 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.2 | 3.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 1.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 0.9 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.2 | 4.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 3.7 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.2 | 2.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 1.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 1.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 2.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.6 | GO:0001096 | TFIIF-class transcription factor binding(GO:0001096) |
0.2 | 1.7 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.2 | 1.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.6 | GO:0019798 | procollagen-proline dioxygenase activity(GO:0019798) |
0.2 | 2.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 3.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 1.1 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 1.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 3.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 1.2 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.2 | 2.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.7 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 2.0 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 9.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.8 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 2.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 7.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.8 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.1 | 4.5 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 3.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.1 | 1.8 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 1.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 4.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 2.1 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 3.6 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 3.2 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 1.3 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.1 | 5.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 4.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 2.0 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.1 | 0.5 | GO:0004078 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
0.1 | 2.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 2.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.1 | 3.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.5 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 1.8 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 2.0 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 2.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 1.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.1 | 1.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 1.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 1.8 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 2.2 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 1.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.7 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.1 | 1.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 2.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 5.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 3.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 2.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.1 | 5.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 2.2 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 1.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 3.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 5.0 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 1.2 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 1.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 1.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 28.8 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.1 | 19.9 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 2.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.6 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 0.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 1.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 2.1 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 3.3 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 12.2 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 3.6 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.0 | 2.8 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.8 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 2.0 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 1.6 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.0 | 0.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 1.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.8 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.3 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.0 | 0.2 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.0 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.0 | 0.8 | GO:0070717 | poly-purine tract binding(GO:0070717) |
0.0 | 1.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.8 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.0 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 2.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 2.5 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 3.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.9 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.1 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.6 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 4.0 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 2.0 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.0 | 0.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 4.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 2.2 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 1.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 5.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 1.2 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.0 | 1.3 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 1.0 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.2 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 1.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 1.2 | GO:0019842 | vitamin binding(GO:0019842) |
0.0 | 0.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 10.0 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 8.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.3 | 11.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.3 | 3.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 10.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.2 | 12.8 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 2.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 12.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 6.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.2 | 5.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.2 | 2.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 5.6 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 2.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 8.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 6.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.1 | 4.1 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 4.8 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 3.4 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 11.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 7.7 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.8 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 5.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 2.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 4.1 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 4.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 1.5 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 2.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 10.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 1.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 3.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 6.3 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 4.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 5.2 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.5 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 2.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 0.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.7 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 8.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 1.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 3.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 3.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 2.0 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 7.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 2.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.2 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 1.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 0.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 0.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.5 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 8.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 12.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.3 | 7.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 4.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.3 | 6.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 4.9 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.2 | 2.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 2.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 2.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 4.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.2 | 6.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 4.0 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.2 | 6.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 3.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.2 | 1.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 1.9 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.2 | 2.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 11.0 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 2.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.2 | 4.1 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.1 | 6.8 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 3.3 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.8 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 6.6 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 4.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.0 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 3.8 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 2.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.8 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 1.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.1 | 1.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 1.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 5.1 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 2.5 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 1.3 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 3.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 1.4 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 2.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 2.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 2.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 9.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 0.3 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 1.7 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 2.2 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 7.3 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 2.1 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 4.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.8 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 1.3 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.1 | 0.6 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 2.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 4.3 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 0.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 1.7 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 1.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 3.0 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.0 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 1.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 0.8 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.9 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 4.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 1.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 1.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 1.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 6.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 2.4 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 1.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 2.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 2.6 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 2.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |